Page last updated: 2024-10-16

beta-alanine and Lacrimal Duct Obstruction

beta-alanine has been researched along with Lacrimal Duct Obstruction in 1 studies

Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)

Research Excerpts

ExcerptRelevanceReference
"Presence of punctal stenosis after topical netarsudil use and resolution of punctal stenosis after cessation of therapy."1.72Punctal Stenosis Associated with Topical Netarsudil Use. ( Chen, PP; Meirick, TM; Mudumbai, RC; Zhang, MM, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Meirick, TM1
Mudumbai, RC1
Zhang, MM1
Chen, PP1

Other Studies

1 other study available for beta-alanine and Lacrimal Duct Obstruction

ArticleYear
Punctal Stenosis Associated with Topical Netarsudil Use.
    Ophthalmology, 2022, Volume: 129, Issue:7

    Topics: Benzoates; beta-Alanine; Constriction, Pathologic; Eyelid Diseases; Glaucoma; Humans; Lacrimal Duct

2022